American Journal of Preventive Cardiology
Study design, rationale, and baseline characteristics of ATTAIN-HYPERTENSION, a phase 3 trial of the oral GLP-1 receptor agonist orforglipron for hypertension
Trial in 546 peopleGLP-1 receptor agonists
Papers by Cathy Xie
3 results
- Journal of Clinical Sleep Medicine
Association of tirzepatide with changes in OSA-related measures based on baseline characteristics - post hoc analyses of SURMOUNT-OSA
Randomised trial in peopleTirzepatide - ADA Scientific Sessions 2026 Abstract
Comparing Incidence of Diabetes Complications and Mortality between Breast and Colon Cancers: A TriNetX Study
Study in peoplePopulations